This prespecified, exploratory subgroup analysis of PALOMA-2 suggests that palbociclib–letrozole is effective for postmenopausal Japanese women with ER+/HER2– ABC who have not received prior systemic treatment for ABC. Here, ERBB2 is linked to aneurysmal bone cyst.